Skip to main content
Premium Trial:

Request an Annual Quote

Nonlinear Dynamics Signs First Progenesis Distribution Deals with PerkinElmer, APB


Nonlinear Dynamics signed the first distributor agreements for its recently launched Progenesis 2D electrophoresis image analysis software last week. PerkinElmer Life Sciences and Amersham Pharmacia Biotech each agreed to distribute the software to complement their ProXpress and Ettan proteomics systems, respectively.

“Both are very important deals for us,” said Will Dracup, CEO of Nonlinear Dynamics. He noted that they each follow on existing deals for the company’s Phoretix line of image analysis software.

The Progenesis line builds on existing image analysis technology by automating the process, Dracup said. It is the first product to emerge from the company’s nonlinear technology development approach, described as a combination of automation techniques with image and profile analysis, data mining, statistical processing, data presentation, relationship studies, system integration, and interface design.

“Life is inherently nonlinear,” Dracup said. “So it would make sense for the tools that are examining life to be nonlinear too.”

Dracup said that Progenesis is the first software able to automate 2D gel image analysis. Currently, he said, industrial users run hundreds of gels a day, but each can take between two and eight hours of editing by a PhD-level researcher. The Progenesis system can automatically analyze a gel in five minutes, Dracup said.

The next product in the nonlinear technology pipeline is Progenera, a scalable Oracle database that will integrate information generated by Progenesis and other data sources. Dracup said Nonlinear Dynamics is also developing a distributed computing system called Accelerator, which will automatically distribute Progenesis analysis jobs to a bank of processors. Dracup said the Accelerator system scales linearly.

The new products are slated for commercial release in the first quarter of 2002. Dracup said the company intends to continue to leverage its existing client base as it expands into new areas.

Dracup said Nonlinear Dynamics is also seeking to increase its staff by 50 percent by the end of the financial year.

— BT

Filed under

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.